OLR1 and acute coronary syndrome: (2005) found that increased level of sLOX‐1 could reflect the vulnerability of plaque, since elevated levels of soluble receptors might weaken fibrous caps, which would lead to plaque disruption, eventually causing acute coronary syndrome.